Analysts at StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research report issued on Tuesday. The firm set a “hold” rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Stock Performance
NASDAQ:SRNE opened at $0.01 on Tuesday. Sorrento Therapeutics has a one year low of $0.00 and a one year high of $0.42. The firm’s 50 day simple moving average is $0.01 and its 200 day simple moving average is $0.03.
About Sorrento Therapeutics
Want More Great Investing Ideas?
Featured Articles
- Five stocks we like better than Sorrento Therapeutics
- What is a Secondary Public Offering? What Investors Need to Know
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- How to Evaluate a Stock Before BuyingÂ
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- What Are the U.K. Market Holidays? How to Invest and Trade
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.